ITGAX and hepatocellular carcinoma: Consistent with development of an immune suppressive TME within hMet + S45Y ß-catenin liver (SB-HCC) tumors, expression of PD-L1 on liver infiltrating CD11c+/MHCII+ dendritic cells was significantly increased in tumor bearing compared to non-tumor bearing mice (Fig. 1G).